Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have more sleep problems than the general population.

Certain medications can reduce sexual desire and function, especially in women.

Diabetes causes lasting cell dysfunctions, leading to serious complications even after blood sugar is controlled.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Finasteride, a drug used for certain conditions, can cause serious side effects like sexual dysfunction, suicidal thoughts, and increased diabetes risk, and there's a need for more awareness and research about these effects.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Improving mitochondrial health may better treat atherosclerosis than antioxidants.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Women with PCOS are much more likely to experience depression.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Lower LDL-c levels predict higher COVID-19 mortality.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

A group has developed therapies that show promise for treating cancer and various other conditions.

Meis2 is essential for touch sensation and proper nerve connection to touch receptors in certain skin areas of mice.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

New treatments like nanotechnology show promise in improving skin cancer therapy.